Ending the Diagnostic Odyssey Act of 2019
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Aug 2, 2019)
Ending the Diagnostic Odyssey Act of 2019
This bill allows state Medicaid programs to cover whole genome sequencing services for certain individuals.
Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to an intensive care unit or seen by a medical specialist for a suspected genetic or undiagnosed disease, or (2) are suspected by a medical specialist to have a neonatal- or pediatric-onset genetic disease.
The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services.
What just happenedAug 5, 2019
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseAug 2, 2019
- Aug 5, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Aug 2, 2019IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Aug 2, 2019IntroReferralIntro-H
Introduced in House
- Aug 2, 2019IntroReferral1000
Introduced in House